The pharmaceutical industry spends more on marketing than on research, and this film traces where that money goes. Doctors, media scholars, and public health researchers walk through the mechanics of direct-to-consumer drug ads, the sponsored medical conferences, and the practice critics call "disease mongering," where ordinary conditions like shyness or low energy get rebranded as treatable disorders with a pill already waiting. Archival ad footage for antidepressants and erectile dysfunction drugs sits alongside interviews explaining how a condition's public image can be shaped well before a treatment for it exists. The film follows the money from pharmaceutical company boardrooms to medical journals, professional associations, and even patient advocacy groups, showing how industry funding can quietly shape which diseases get attention and which drugs get prescribed. Rather than arguing medicine itself is corrupt, the film asks a narrower question: what happens to healthcare when the definition of illness becomes a marketing decision. It closes with clinicians describing the pressure they feel from patients who arrive already diagnosed by an ad.